{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:44:27Z","timestamp":1790801067846,"version":"4.1.0"},"reference-count":24,"publisher":"Massachusetts Medical Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NEJM Evidence"],"published-print":{"date-parts":[[2022,1,25]]},"DOI":"10.1056\/evidoa2100043","type":"journal-article","created":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T23:46:05Z","timestamp":1640130365000},"source":"Crossref","is-referenced-by-count":82,"title":["Phase 2\/3 Trial of Molnupiravir for Treatment of Covid-19 in Nonhospitalized Adults"],"prefix":"10.1056","volume":"1","author":[{"given":"Yoseph","family":"Caraco","sequence":"first","affiliation":[{"name":"Clinical Pharmacology Unit, Hadassah-Hebrew University Medical Center, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon E.","family":"Crofoot","sequence":"additional","affiliation":[{"name":"Crofoot Research Center, Inc., Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo Andres","family":"Moncada","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Infectious Disease Service, Fundaci\u00f3n Valle del Lili, Cali, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Nikolaevna","family":"Galustyan","sequence":"additional","affiliation":[{"name":"Saint Petersburg State Pediatric Medical University, Saint Petersburg, Russia"},{"name":"Strategic Medical System LLC, Saint Petersburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dany Badibanga","family":"Musungaie","sequence":"additional","affiliation":[{"name":"Jongaie Research, Gauteng, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Payne","sequence":"additional","affiliation":[{"name":"Departments of Infectious Diseases and Medical Virology, Newcastle upon Tyne Hospitals, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeniy","family":"Kovalchuk","sequence":"additional","affiliation":[{"name":"Medical Research Institute LLC, Saint Petersburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Advanced Research for Health Improvement LLC, Immokalee, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle L.","family":"Brown","sequence":"additional","affiliation":[{"name":"Merck Research Laboratories, Merck & Co., Inc., Kenilworth, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Williams-Diaz","sequence":"additional","affiliation":[{"name":"Merck Research Laboratories, Merck & Co., Inc., Kenilworth, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Gao","sequence":"additional","affiliation":[{"name":"Merck Research Laboratories, Merck & Co., Inc., Kenilworth, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Strizki","sequence":"additional","affiliation":[{"name":"Merck Research Laboratories, Merck & Co., Inc., Kenilworth, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Grobler","sequence":"additional","affiliation":[{"name":"Merck Research Laboratories, Merck & Co., Inc., Kenilworth, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiejun","family":"Du","sequence":"additional","affiliation":[{"name":"Merck Research Laboratories, Merck & Co., Inc., Kenilworth, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Assaid","sequence":"additional","affiliation":[{"name":"Merck Research Laboratories, Merck & Co., Inc., Kenilworth, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Paschke","sequence":"additional","affiliation":[{"name":"Merck Research Laboratories, Merck & Co., Inc., Kenilworth, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan R.","family":"Butterton","sequence":"additional","affiliation":[{"name":"Merck Research Laboratories, Merck & Co., Inc., Kenilworth, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew G.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Merck Research Laboratories, Merck & Co., Inc., Kenilworth, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carisa","family":"De Anda","sequence":"additional","affiliation":[{"name":"Merck Research Laboratories, Merck & Co., Inc., Kenilworth, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_5_2_2","unstructured":"World Health Organization. WHO Coronavirus (COVID-19) Dashboard (https:\/\/covid19.who.int\/)."},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6924e2"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00766-18"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-020-00835-2"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb5883"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03312-w"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01965-17"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab247"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2014.09.007"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab362"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2116044"},{"key":"e_1_3_5_18_2","unstructured":"Chawla A Cao Y Stone J et\u00a0al. Model-based dose selection for the phase 3 evaluation of molnupiravir in the treatment of COVID-19 in adults. Poster presented at the 2021 ECCMID Annual Meeting Vienna Austria. July 9-12 2021 (https:\/\/eacademy.escmid.org\/escmid\/2021\/eccmid-2021\/332297\/)."},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780040211"},{"key":"e_1_3_5_20_2","first-page":"1","article-title":"Antiviral agents for the treatment and chemoprophylaxis of influenza \u2014 recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"60","year":"2011","unstructured":"Fiore AE, Fry A, Shay D, Gubareva L, Bresee JS, Uyeki TM. Antiviral agents for the treatment and chemoprophylaxis of influenza \u2014 recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011;60:1-24.","journal-title":"MMWR Recomm Rep"},{"key":"e_1_3_5_21_2","unstructured":"GlaxoSmithKline. Fact Sheet for Healthcare Providers Emergency Use Authorization (EUA) of Sotrovimab. Updated November 2021 (https:\/\/gskpro.com\/content\/dam\/global\/hcpportal\/en_US\/Prescribing_Information\/Sotrovimab\/pdf\/SOTROVIMAB-EUA.PDF#nameddest=HCPFS2021)."},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.0202"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035002"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01348-19"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.1.244-254.2003"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01294-w"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03412-7"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abg3055"},{"key":"e_1_3_5_29_2","unstructured":"Grobler J Strizki J Murgolo N et\u00a0al. Molnupiravir maintains antiviral activity against SARS-CoV-2 variants in\u00a0vitro and in early clinical studies. Presented at ID Week September 19 to October 3 2021 (https:\/\/idweek.junolive.co\/welcome2021)."},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2100044"}],"container-title":["NEJM Evidence"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T18:11:51Z","timestamp":1651169511000},"score":1,"resource":{"primary":{"URL":"https:\/\/evidence.nejm.org\/doi\/10.1056\/EVIDoa2100043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,25]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,1,25]]}},"alternative-id":["10.1056\/EVIDoa2100043"],"URL":"https:\/\/doi.org\/10.1056\/evidoa2100043","relation":{},"ISSN":["2766-5526"],"issn-type":[{"value":"2766-5526","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,25]]}}}